Title |
First-in-class ultralong-target-residence-time p38α inhibitors as a mitosis-targeted therapy for colorectal cancer |
|---|---|
Involved |
Ramona Rudalska (Verfasser)
Jule Harbig (Verfasser) Michael Forster (Verfasser) Pascal Woelffing (Verfasser)
Aylin Esposito (Verfasser)
Mark Kudolo (Verfasser) Adelina Botezatu (Verfasser) Vanessa Haller (Verfasser) Nicole Janssen (Verfasser) Samuel J. Holzmayer (Verfasser) Philipp Nahidino (Verfasser) Omelyan Trompak (Verfasser) Tatu Pantsar (Verfasser) Thales Kronenberger (Verfasser) Can Yurttas (Verfasser) Elke Rist (Verfasser) Alexander N. R. Weber (Verfasser) Marc H. Dahlke (Verfasser) German Ott (Verfasser) Alfred Koenigsrainer (Verfasser) Ulrich Rothbauer (Verfasser) Melanie Märklin (Verfasser) Thomas Muerdter (Verfasser) Matthias Schwab (Verfasser) Stephan Singer (Verfasser) Lars Zender (Verfasser) Stefan Laufer (Verfasser) Daniel Dauch (Verfasser) SpringerLink (Online service) (Sonstige) |
Published in |
Nature cancer 6, 2, 16.1.2025, date:2.2025, Seite 259-277 |
Published |
2025 |
Language |
|
Country |
|
Topic |
|
Subject |
Biomedical Research.
Clinical Research. Biological Sciences. Cancer Biology.
Genetics and Genomics.
Immunology. |
DDC notation |
|
Persistent identifier |
urn:nbn:de:101:1-2505142128224.609954945001 (URN) |
Record ID |
1365652289 |
Please note
The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link: